King-Devick technologies, inc. (KDT) offers a broad set of evidence-based tools utilizing integrated technology for concussion pitchside screening, reading performance, and as indicators of neurological function.
King-Devick products have been scientifically validated in more than 200 recent peer reviewed articles published in elite medical journals related to concussion management, reading solutions, migraine headaches, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease, extreme sleep deprivation, ALS and age-related macular degeneration (AMD).
As Featured In
